Medolla (Modena, Italy), December 2022 \u2013 Eurosets, a company based in Medolla (Italy) leader in the development, production and commercialization of advanced medical devices, announces the first patient treated with Colibr\u00ec, the lightest extracorporeal life support (ECLS) system available in the market.<\/p>\n\n\n\n
Colibr\u00ec received CE-Mark in October 2022 and complements and expands Eurosets ECLS portfolio with the objective to provide temporary support to patients suffering from ventricular failure, cardiac arrest or respiratory failure in a variety of different applications, including extracorporeal membrane oxygenation (ECMO), extracorporeal cardiopulmonary resuscitation (E-CPR) and mechanical circulatory support (MCS).<\/p>\n\n\n\n
The first clinical procedure using Colibr\u00ec was performed by a team led by Pr Philippe Gaudard, head of the ICU department at the Arnaud de Villeneuve university Hospital of Montpellier, France. The patient was supported on VA-ECMO and successfully weaned after few days of treatment.<\/p>\n\n\n\n
\n<\/p>\n\u201cI truly believe that Colibr\u00ec has the potential to become the new standard of care for ECLS \u2013 said Dr. Gaudard<\/strong> \u2013 Colibr\u00ec, with its lightweight design, ensures that ECLS can be delivered by the specialised mobile ECMO team whenever and wherever is needed and, through its unique features, allows us to initiate ECMO therapy in a safe, easy and reproducible way with advanced monitoring\u201d.<\/cite><\/blockquote>\n\n\n\n
Featuring a fully magnetic-levitating centrifugal pump that covers adult, paediatric and new-born patients, a series of advanced monitoring capabilities and a complete integration with ECMOLife, Colibr\u00ec is the lightest device available in the market. The breakthrough device developed by Eurosets is also the only one equipped with a wi-fi connection that allows innovative remote monitoring, thereby ensuring greater patient safety and easier management for healthcare professionals. A set of unique transport accessories, designed to perform ECLS even in the most difficult scenarios, makes Colibr\u00ec the only device available in the market truly able to perform ECLS treatments everywhere there is a life to save.<\/p>\n\n\n\n
\n<\/p>\n\u201cWe are proud to launch Colibr\u00ec, an innovative system that complements our ECLS offering \u2013 said Antonio Petralia, CEO and Executive Vice President of Eurosets<\/strong> \u2013 Our vision is to reimagine ECLS treatments while responding to diverse medical needs through meaningful innovation and Colibr\u00ec is fully in line with these core beliefs\u201d.<\/cite><\/blockquote>\n\n\n\n
Colibr\u00ec is currently being introduced in selected European centers as part of a controlled launch, after which a full international commercial release will follow upon achievement of local approvals.<\/p>\n","protected":false},"excerpt":{"rendered":"
Medolla (Modena, Italy), December 2022 \u2013 Eurosets, a company based in Medolla (Italy) leader in the development, production and commercialization of advanced medical devices, announces the first patient treated with Colibr\u00ec, the lightest extracorporeal life support (ECLS) system available in the market. Colibr\u00ec received CE-Mark in October 2022 and complements and expands Eurosets ECLS portfolio […]<\/p>\n","protected":false},"author":5,"featured_media":1649,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"slim_seo":{"title":"Eurosets announces first patient treated with Colibr\u00ec, the lightest Extracorporeal Life Support System - Eurosets","description":"Medolla (Modena, Italy), December 2022 \u2013 Eurosets, a company based in Medolla (Italy) leader in the development, production and commercialization of advanced me"},"footnotes":""},"categories":[35],"tags":[],"class_list":["post-1332","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-innovation"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.eurosets.com\/en\/wp-json\/wp\/v2\/posts\/1332","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.eurosets.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.eurosets.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.eurosets.com\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.eurosets.com\/en\/wp-json\/wp\/v2\/comments?post=1332"}],"version-history":[{"count":1,"href":"https:\/\/www.eurosets.com\/en\/wp-json\/wp\/v2\/posts\/1332\/revisions"}],"predecessor-version":[{"id":9704,"href":"https:\/\/www.eurosets.com\/en\/wp-json\/wp\/v2\/posts\/1332\/revisions\/9704"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.eurosets.com\/en\/wp-json\/wp\/v2\/media\/1649"}],"wp:attachment":[{"href":"https:\/\/www.eurosets.com\/en\/wp-json\/wp\/v2\/media?parent=1332"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.eurosets.com\/en\/wp-json\/wp\/v2\/categories?post=1332"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.eurosets.com\/en\/wp-json\/wp\/v2\/tags?post=1332"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}